+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

IL-12-Independent costimulation pathways for interferon-gamma production in familial disseminated Mycobacterium avium complex infection



IL-12-Independent costimulation pathways for interferon-gamma production in familial disseminated Mycobacterium avium complex infection



Clinical Immunology 91(2): 234-241



We have described previously a family with an apparent genetic susceptibility to disseminated Mycobacterium avium complex infection and an underlying defect in IL-12 regulation leading to abnormally low interferon-gamma production. Their T cells appear to act normally when in the presence of normal accessory cells. Cell-to-cell contact was necessary for normal monocytes to complement the familial patient monocyte defect, suggesting the familial defect in interferon-gamma costimulation involves pathways requiring cell surface molecule interactions. In an effort to better characterize the abnormality in these patients, we examined the role of known costimulatory molecules in residual costimulation by patient PBMC compared to normals. Whereas normals utilized CD40/CD40L interactions and IL-12 production for optimal interferon-gamma costimulation in PHA-stimulated cocultures, familial patient interferon-gamma production was low and unaffected by their blockade. CD86 blockade caused a greater than 50% reduction in both normal and familial patient interferon-gamma production, implying that a majority of residual familial patient costimulation required this pathway. Furthermore, selected myelomonocytic cell lines (K562 and THP1) acted as potent accessory cells for interferon-gamma production by familial patient and normal T cells, largely independent of IL-12 production. However, CD86 blockade of K562 cell/familial cell cocultures resulted in less than a 20% reduction in interferon-gamma production, indicating that familial patient cells respond to IL-12- and CD86-independent costimulatory signals for interferon-gamma as well. Thus, we demonstrate that the familial defect also involves interferon-gamma costimulation pathways requiring both CD40/CD40L interaction and IL-12 production, while residual pathways remain that allow low-level interferon-gamma production. Familial Mycobacterium avium patient monocytes and certain myelomonocytic cell lines can be exploited to investigate IL-12-independent costimulation for interferon-gamma production.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010777285

Download citation: RISBibTeXText

PMID: 10227816

DOI: 10.1006/clim.1999.4688


Related references

Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. Journal of Immunology 157(1): 411-416, 1996

Defective monocyte costimulation for IFN-c production in familial disseminated Mycobacterium avium complex infection. Abnormal IL-12 regulation. Journal of Immunology 157: 1-16, 1996

Disseminated Mycobacterium avium infection without HIV infection is associated with defective interferon gamma production and responds to treatment with interferon gamma. Clinical Research 41(2): 321A, 1993

Interferon gamma receptor deficiency in disseminated Mycobacterium avium complex infection. Journal of Investigative Medicine 45(3): 199A, 1997

Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma. Internal Medicine 46(13): 1005-1009, 2007

Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. European Journal of Pediatrics 166(9): 981-985, 2007

Defective production of interferon gamma and interleukin 12 in a boy with disseminated Mycobacterium avium infection. Hormone Research 48(Suppl. 2): 195, 1997

Disseminated Mycobacterium avium complex infection in a child with partial dominant interferon gamma receptor 1 deficiency in India. Journal of Clinical Immunology 35(5): 459-462, 2015

Effective combination therapy using interferon-gamma and interleukin-2 for disseminated Mycobacterium avium complex infection in a pediatric patient with AIDS. Clinical Infectious Diseases 41(11): E104-E106, 2005

Successful HLA-identical bone marrow transplantation in a patient with interferon-gamma receptor 2 deficiency and disseminated Mycobacterium avium complex infection. Journal of Allergy & Clinical Immunology 113(2 Suppl.): S44, 2004

Interferon gamma therapy in a boy with a mutation in the interferon gamma receptor and disseminated Mycobacterium avium infection. Hormone Research (Basel) 50(Suppl. 3): 94, 1998

Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. Journal of Infection and ChemoTherapy 15(2): 118-122, 2009

Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies. Journal of Clinical Immunology 35(4): 361-365, 2015

Interleukin-12 deficiency in patients with familial disseminated Mycobacterium avium complex infection. Journal of Investigative Medicine 43(Suppl. 2): 364A, 1995

Interferon alpha treatment for disseminated M avium complex infection in complete interferon gamma receptor 2 deficiency. Journal of Allergy & Clinical Immunology 111(2 Abstract Suppl.): S222, 2003